Showing results 1 to 20 of 24
next >
| Issue Date | Title | Author(s) |
| 2024 | Advancements in Platinum Chemotherapy for Metastatic Castration-Resistant Prostate Cancer: Insights and Perspectives | Akkuş, Erman; Arslan, Çağatay ; Ürün, Yüksel |
| 2022 | Biomarker Analysis and Updated Results From the Phase Iii Propel Trial of Abiraterone (abi) and Olaparib (ola) Vs Abi and Placebo (pbo) as First-Line (1l) Therapy for Patients (pts) With Metastatic Castration-Resistant Prostate Cancer (mcrpc) | Saad, F.; Armstrong, A. J.; Thiery-Vuillemin, A.; Oya, M.; Shore, N. D.; Procopio, G.; Arslan, C. |
| 2023 | Case Report-Right Atrial Mass: a Very Rare Presentation of Endometrial Cancer Metastasis | Ertürk, Emre ; Söyler, Onur; Pehlivan, Fatma Seher; Arslan, Çagatay |
| 2023 | Central Nervous System Outcomes of Lazertinib Versus Gefitinib in Egfr-Mutated Advanced Nsclc: a Laser301 Subset Analysis | Soo, R.A.; Cho, B.C.; Kim, J.-H.; Ahn, M.-J.; Lee, K.H.; Zimina, A.; Orlov, S.; Hana Lee; Arslan, Çağatay |
| 2023 | Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: a Multicenter Study From the Turkish Oncology Group Kidney Cancer Consortium | Erol, Cihan; Yekeduz, Emre; Tural, Deniz; Karakaya, Serdar; Şentürk Öztaş, Nihan; Uçcar, Gökhan; Kılıçkap, Saadettin; Arslan, Çağatay |
| 2022 | Cutaneous Metastasis of Bladder Urothelial Carcinoma; a Rare Conditions | Oztuerk, Hakan; Yurtsever, Selin; Ozer, Arzum; Arslan, Cagatay ; Tekeli, Aysun; Pehlivan, Fatma Seher |
| 2023 | The Efficacy of Immunotherapy and Chemoimmunotherapy in Patients With Advanced Rare Tumors: a Turkish Oncology Group (tog) Study | Güven, Deniz Can; Aykan, Musa Barış; Muglu, Harun; Bayram, Ertuğrul; Helvacı, Kaan; Dursun, Bengue; Celayir, Melisa; Arslan, Çağatay |
| 2023 | Efficacy of Olaparib (ola) Plus Abiraterone (abi) Vs Placebo (pbo) Plus Abi in the Non-Brca Mutation (non-Brcam) Subgroup of Patients (pts) With Metastatic Castration-Resistant Prostate Cancer (mcprc) in the Propel Trial | Mehra, N.; Clarke, N. W.; Armstrong, A. J.; Oya, M.; Shore, N. D.; Procopio, G.; Guedes, J. D. C.; Arslan, Çağatay |
| 2023 | External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (imdc): Results From the Turkish Oncology Group Kidney Cancer Consortium (tkcc) Database | Yekeduz, Emre; Karakaya, Serdar; Erturk, Ismail; Tural, Deniz; Ucar, Gokhan; Oztas, Nihan Senturk; Arikan, Rukiye; Arslan, Çağatay |
| 2023 | Five-Year Outcome and Safety in Patients Treated With Immune Checkpoint Blockade Therapies for Urothelial Carcinoma: Experience From Real-World Clinical Practice | Tural D.; Arslan C. ; Selcukbiricik F.; Olmez O.F.; Akar E.; Erman M.; Ürün Y. |
| 2024 | Immune Checkpoint Blockade Therapies Efficacy and Toxicity in Patients With Impaired Renal Function in Metastatic Bladder Cancer | Tural, Deniz; Arslan, Cagatay ; Selcukbiricik, Fatih; Olmez, Omer Fatih; Akar, Emre; Erman, Mustafa; Ueruen, Yueksel |
| 2022 | Long-Term Outcome and Safety in Patients Treated With Immune Checkpoint Blockade Therapies for Urothelial Carcinoma: Experience From Real-World Clinical Practice. | Tural, Deniz; Arslan, Cagatay ; Selcukbiricik, Fatih; Olmez, Omer Fatih; Erman, Mustafa; Urun, Yuksel; Karadurmus, Nuri |
| 2022 | Modified Docetaxel, Cisplatin, and 5-Fluorouracil Combination Regimen and Capecitabine Maintenance in Metastatic Gastric Cancer: Toxicity and Efficacy Results | Arslan, Cagatay ; Atilla, Fatos Dilan |
| 2024 | Objective Response Rate Is a Surrogate Marker for Long-Term Overall Survival in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors | Tural, Deniz; Arslan, Çagatay ; Selçukbiricik, Fatih; Ölmez, Ömer Fatih; Erman, Mustafa; Ürün, Yüksel; Erdem, Dilek |
| 2023 | Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in Metastatic Castration-Resistant Prostate Cancer (propel): Final Prespecified Overall Survival Results of a Randomised, Double-Blind, Phase 3 Trial | Saad, F.; Clarke, N.W.; Oya, M.; Shore, N.; Procopio, G.; Guedes, J.D.; Arslan, Çağatay |
| 2024 | Perceptions and Expectations: a Study on Prognostic Perception and Quality of Life in Patients With Metastatic Renal and Bladder Cancer | Bölek, Hatice; Arslan, Çagatay ; Başaran, Mert; Cicin, Irfan; Ozguroglu, Mustafa; Tural, Deniz; Ürün, Yüksel |
| 2024 | Perceptions and Expectations: a Study on Prognostic Perception and Quality of Life in Patients With Metastatic Renal and Bladder Cancer. | Bolek, Hatice; Arslan, Cagatay ; Başaran, Mert; Cicin, İrfan; Ozguroglu, Mustafa; Tural, Deniz; Ürün, Yüksel |
| 2023 | Perspectives and Knowledge About Fertility Preservation Strategies Among Female Cancer Patients in Turkey | Emirdar, Volkan ; Karatasli, Volkan; Acet, Ferruh; Okay, Gulin ; Gode, Funda ; Karabulut, Alaattin; Arslan, Cagatay |
| 2021 | Real-Life Experience With Chemotherapy Plus Biologics in First-Line Treatment of Right-Sided, Ras Wild-Type, Metastatic Colon Cancer: a Multicenter Onco-Colon Turkey Study | Arslan, Çağatay ; Kefeli, U.; Yildirim, E.; Isikdogan, A.; Karadurmus, N.; Karabulut, B.; Cicin, I. |
| 2021 | Real-World Treatment Outcomes From Nationwide Onco-Colon Turkey Registry in Ras Wild-Type Patients Treated With Biologics First-Line Metastatic Colorectal Cancer. | Kefeli, Umut; Arslan, Cagatay ; Yildirim, Mahmut Emre; Isikdogan, Abdurrahman; Karadurmus, Nuri; Karabulut, Bulent; Cubukcu, Erdem |
